Morning Overview on MSN
A cell therapy for an aggressive childhood leukemia just won breakthrough status
Children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia now have a new reason to pay attention.
The treatment landscape of chronic lymphocytic leukaemia has undergone a revolution in the past decade. Highly effective ...
Maxton Bowman, 2, was diagnosed with acute lymphoblastic leukemia after months of unexplained symptoms.
Current tyrosine kinase inhibitors (TKIs) used to treat Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) inhibit the catalytic site of the BCR::ABL1 oncoprotein and are ...
In most cases, acute lymphoblastic leukemia (ALL) manifests as a de novo malignancy in previously healthy people. Risk factors for developing ALL include age older than 70 years and genetic disorders, ...
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in ...
Infantile ALL occurs in children under age one. It’s a rare and aggressive leukemia that typically has a poor outlook. Treatment involves chemo and sometimes a stem cell transplant. Leukemia refers to ...
PVR demonstrated superiority versus VR in the ITT analysis population; benefits consistent across prespecified subgroups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results